Combining Checkpoint and Tyrosine Kinase Inhibitor in the Treatment of Renal Cell Carcinoma

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [1] Adjuvant therapy in renal cell carcinoma: Tyrosine kinase inhibitor versus immune checkpoint inhibitor
    Zhou, Qingbo
    Liu, Jianjiang
    Xie, Shaoqin
    MEDICINE, 2024, 103 (22) : E38329
  • [2] Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
    Stuhler, Viktoria
    Rausch, Steffen
    Maas, Jan Moritz
    Stenzl, Arnulf
    Bedke, Jens
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1215 - 1226
  • [3] Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
    Gu, L.
    Liang, Q.
    Zhang, X.
    Wang, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1507 - S1507
  • [4] Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
    Harada, Mirii
    Tomisaki, Ikko
    Shimajiri, Shohei
    Kuretake, Keisuke
    Harada, Kenichi
    Fujimoto, Naohiro
    IJU CASE REPORTS, 2023, 6 (06) : 386 - 389
  • [5] MCT INHIBITION SYNERGIZES WITH TYROSINE KINASE AND MTOR INHIBITOR TREATMENT IN RENAL CELL CARCINOMA
    Jambunathan, Bhaghyasree
    Dergham, Abdo
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2022, 207 (05): : E702 - E702
  • [6] Pazopanib The Newest Tyrosine Kinase Inhibitor for the Treatment of Advanced or Metastatic Renal Cell Carcinoma
    Keisner, Sidney V.
    Shah, Sachin R.
    DRUGS, 2011, 71 (04) : 443 - 454
  • [7] Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3
    Penel, Nicolas
    BULLETIN DU CANCER, 2017, 104 (09) : 705 - 706
  • [8] Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma
    Keisner S.V.
    Shah S.R.
    Drugs, 2011, 71 (4) : 443 - 454
  • [9] Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma
    Yang, Yuanquan
    Psutka, Sarah P.
    Parikh, Anish B.
    Li, Mingjia
    Collier, Katharine
    Miah, Abdul
    Mori, Sherry, V
    Hinkley, Megan
    Tykodi, Scott S.
    Hall, Evan
    Thompson, John A.
    Yin, Ming
    CANCER MEDICINE, 2022, 11 (16): : 3106 - 3114
  • [10] Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
    Hailiang Zhang
    Lin Bai
    Xin-Qiang Wu
    Xi Tian
    Jinwen Feng
    Xiaohui Wu
    Guo-Hai Shi
    Xiaoru Pei
    Jiacheng Lyu
    Guojian Yang
    Yang Liu
    Wenhao Xu
    Aihetaimujiang Anwaier
    Yu Zhu
    Da-Long Cao
    Fujiang Xu
    Yue Wang
    Hua-Lei Gan
    Meng-Hong Sun
    Jian-Yuan Zhao
    Yuanyuan Qu
    Dingwei Ye
    Chen Ding
    Nature Communications, 14
12345